| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/29/2005 | EP1546097A1 Pyrrole derivatives as antimycobacterial compounds |
| 06/29/2005 | EP1546096A1 Process for the preparation of amino-pyrrolidine derivatives |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1237866B1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 06/29/2005 | CN1633439A Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633415A Antibacterial mutilins |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1631879A Substituted phenyl keto enols as pesticides and herbicides |
| 06/29/2005 | CN1631878A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
| 06/29/2005 | CN1631877A Synthesis method of cinepazide maleate |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208320C Method for preparing Cyclohexane maleimide |
| 06/29/2005 | CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/29/2005 | CN1208318C Cycloamine CCR5 receptor antagonists |
| 06/28/2005 | US6911595 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound |
| 06/28/2005 | US6911535 Biomolecule/polymer conjugates |
| 06/28/2005 | US6911501 Process for preparing aspartates |
| 06/28/2005 | US6911468 Useful as a prophylactic or therapeutic agent for diabetes or the like |
| 06/28/2005 | US6911467 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions |
| 06/28/2005 | US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse |
| 06/28/2005 | US6911458 Compounds |
| 06/28/2005 | US6911457 Diabetes imaging probes |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911433 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005057207A1 Trityl derivatives for enhancing mass spectrometry |
| 06/23/2005 | WO2005056526A1 Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates |
| 06/23/2005 | WO2005056004A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 06/23/2005 | WO2005056003A1 Dpp-iv inhibitors |
| 06/23/2005 | US20050137406 Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive of levulinic acid esters with aryl and alkyl amines |
| 06/23/2005 | US20050137248 Anticancer agents; viricides; intiinflamamtory agents; using a sulfonamide containing compound |
| 06/23/2005 | US20050137241 For therapy of epilepsy, epileptogenesis, seizure disorders, convulsions, dyskinesia and neuropathic pain in a mammal |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137229 Novel compounds |
| 06/23/2005 | US20050137191 Nitrate esters and their use for mitigating cellular damage |
| 06/23/2005 | US20050137172 Haloacetamide and azide substituted compounds and methods of use thereof |
| 06/23/2005 | US20050136620 Maleimide compounds in liquid form |
| 06/23/2005 | CA2548742A1 Dpp-iv inhibitors |
| 06/23/2005 | CA2547573A1 N-alkyl pyrroles as hmg-coa reductase inhibitors |
| 06/22/2005 | EP1544196A1 Process for the production of gamma-keto acetals |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542971A1 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 06/22/2005 | EP1542970A1 Pyrrolidone derivatives as maob inhibitors |
| 06/22/2005 | EP1542969A1 Pyrrolidone derivatives as maob inhibitors |
| 06/22/2005 | EP1542968A1 Process for preparing intermediates |
| 06/22/2005 | EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630634A Optically active 2, 5-bisaryl-delta1-pyrrolines and their use as pest control agents |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 06/22/2005 | CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound |
| 06/22/2005 | CN1630510A Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 06/22/2005 | CN1629139A Dialkyl and diaryl tetrasubstituted heterocyclic compounds, preparing process and use thereof |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/22/2005 | CN1207280C Aminomethyl pyrrolidine urea compositions for production of polyurethanes |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908918 Ketone spirocyclopropaneindene compounds; antineoplastic agents to inhibit tumor cell growth in vitro or in vivo; particularly effective against solid tumors and multi-drug resistant tumors |
| 06/21/2005 | CA2159491C Fuel compositions |
| 06/16/2005 | WO2005054278A1 Substituted n-benzyl-lactam derivatives as melanocortin-4 receptor agonists |
| 06/16/2005 | WO2005054192A1 Cosmetic process for preventing or treating the signs of skin ageing or the orange-peel appearance |
| 06/16/2005 | WO2005054191A1 Pyrrole compounds |
| 06/16/2005 | WO2005054190A1 3-aminopyrrolidone derivatives |
| 06/16/2005 | WO2005054189A1 N-acyl-n'-benzyl-alkylendiamino derivatives |
| 06/16/2005 | WO2005054188A1 Imidazole derivatives, processes for preparing them and their uses |
| 06/16/2005 | WO2005054187A1 Methods of preparing compounds useful as protease inhibitors |
| 06/16/2005 | WO2005054186A2 Methods for the preparation of stereoisomerically enriched amines |
| 06/16/2005 | WO2005053663A2 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
| 06/16/2005 | WO2003018854A3 Immobilization of biological molecules onto surfaces coated with monolayers |
| 06/16/2005 | US20050131238 Using substituted maleimide compound |
| 06/16/2005 | US20050131055 Method of manufacturing an amorphous form of the hemi-calcium salt of (3r, 5r) 7-3-phenly-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yl!-3, 5-dihydroxyheptanoic acid (actorvastatin) |
| 06/16/2005 | US20050131019 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 06/16/2005 | US20050130989 (3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)(4-phenylpiperazin-1-yl)methanone; inhibit tubulin polymerization; cancer |
| 06/16/2005 | US20050130981 Compounds |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
| 06/16/2005 | US20050130966 Sodium channel modulators |
| 06/16/2005 | US20050130243 For detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens; kits |
| 06/16/2005 | US20050126782 Acid ammonium salts of an imide of polymaleic anhydride; hydraulic fracturing fluids used in enhanced oil recovery |
| 06/16/2005 | DE10354628A1 2-Ethyl-4,6-dimethyl-phenyl-substituierte Tetramsäure-Derivate 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives |
| 06/16/2005 | DE10331723A1 Kappa-Agonisten Kappa agonists |
| 06/16/2005 | CA2549289A1 Methods for the preparation of stereoisomerically enriched amines |
| 06/16/2005 | CA2547955A1 Methods of preparing compounds useful as protease inhibitors |
| 06/16/2005 | CA2546961A1 N-acyl-n'-benzyl-alkylendiamino derivatives |
| 06/16/2005 | CA2546653A1 3-aminopyrrolidone derivatives |
| 06/15/2005 | EP1541552A1 Process for the recovery of nitroxy compounds from organic solutions and oxidation process |
| 06/15/2005 | EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 06/15/2005 | EP1541143A1 Dpp-iv inhibitors |
| 06/15/2005 | EP1540037A1 Organic salts and their use as reagents in electrochemical reactions |
| 06/15/2005 | EP1539744A2 N-hydroxyamide derivatives possessing antibacterial activity |
| 06/15/2005 | EP1539692A1 Furanone derivatives and methods of making same |
| 06/15/2005 | EP1539688A2 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines |
| 06/15/2005 | EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 06/15/2005 | EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 06/15/2005 | EP1401811B1 Method for producing pyrrolidones |
| 06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 06/15/2005 | CN1626513A Organometallic complexes and organic electroluminescence device using the same |
| 06/15/2005 | CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |